Corporate Profile for Endovasc Ltd. Inc., dated July 23, 1999.--(BUSINESS WIRE)-- The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: July 23, 1999
Company Name: Endovasc Ltd. Inc.
Address: 15001 Walden Road, Suite 108
Montgomery, TX 77356
Main Telephone
Number: 409/448-2222
Internet Home
Page Address
(URL) http://www.endovasc.com
E-mail Address: endovasc@lcc.net
Chief Executive
Officer: Dr. David P. Summers
Chief Operations
Officer: Gary R. Ball
Chief Scientific
Officer: Dr. Dan Lasic
Chief Financial
Officer: Dwight Cantrell, PA
Investor Relations
Contact: Patrick Rost
Business number: 760/942-0015
e-mail address: PMRandco@aol.com
Trading Symbol/
Exchange: ENDV / OTC BB
Industry: Biotechnology
Company description: We're Smiling About Our New Web Page!! And you'll smile, too when you see how easy it is to access the latest company information about ENDV stock, press releases, company history, market and company objectives. You can also subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day" subscribe, take buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company"; our "emailing list" to receive priority news and company information. Endovasc Ltd., Inc (ENDV) is a High Technology Drug Delivery Company who has developed a new medical product that may significantly impact the cardiology cardiology Medical specialty dealing with heart diseases and disorders. It began with the 1749 publication by Jean Baptiste de Sénac of contemporary knowledge of the heart. Diagnostic methods improved in the 19th century, and in 1905 the electrocardiograph was invented. , radiology radiology, branch of medicine specializing in the use of X rays, gamma rays, radioactive isotopes, and other forms of radiation in the diagnosis and treatment of disease. , and oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. markets. The very core of ENDV technology consists of the capability to formulate and produce extremely small drug microspheres called liposomes Liposomes Aqueous compartments enclosed by lipid bilayer membranes; liposomes are also known as lipid vesicles. Phospholipid molecules consist of an elongated nonpolar (hydrophobic) structure with a polar (hydrophilic) structure at one end. , which are coated with dissolvable fat or detergents, that time-release within a specific blood vessel blood vessel n. An elastic tubular channel, such as an artery, a vein, a sinus, or a capillary, through which the blood circulates. blood vessel(s), n the network of muscular tubes that carry blood. or target organ target organ n. A tissue or organ that is affected by a specific hormone. target organ, n the organ or body part whose activity levels demonstrate change in the course of biofeedback. tissue. ENDV's markets exceed $2 billion and primarily focus on diagnosis and treatment of heart disease and cancer. We welcome your comments and questions about our new web page and Endovasc Ltd., Inc. Visit Our Web Page Today: http://www.endovasc.com or to review our latest SEC Filings, See EDGER.com (a) (a) Expected filing by 8-30-99 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion